Development of the Integrated Glaucoma Risk Index.

Diagnostics (Basel)

Department of Ophthalmology, Institute of Health Sciences, Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Jinju 52828, Korea.

Published: March 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Various machine-learning schemes have been proposed to diagnose glaucoma. They can classify subjects into 'normal' or 'glaucoma'-positive but cannot determine the severity of the latter. To complement this, researchers have proposed statistical indices for glaucoma risk. However, they are based on a single examination indicator and do not reflect the total severity of glaucoma progression. In this study, we propose an integrated glaucoma risk index (I-GRI) based on the visual field (VF) test, optical coherence tomography (OCT), and intraocular pressure (IOP) test. We extracted important features from the examination data using a machine learning scheme and integrated them into a single measure using a mathematical equation. The proposed index produces a value between 0 and 1; the higher the risk index value, the greater the risk/severity of glaucoma. In the sanity test using test cases, the I-GRI showed a balanced distribution in both glaucoma and normal cases. When we classified glaucoma and normal cases using the I-GRI, we obtained a misclassification rate of 0.07 (7%). The proposed index is useful for diagnosing glaucoma and for detecting its progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947311PMC
http://dx.doi.org/10.3390/diagnostics12030734DOI Listing

Publication Analysis

Top Keywords

glaucoma risk
12
glaucoma
9
integrated glaucoma
8
cases i-gri
8
glaucoma normal
8
normal cases
8
development integrated
4
risk
4
risk machine-learning
4
machine-learning schemes
4

Similar Publications

Aims: Chronic ocular diseases such as age-related macular degeneration (AMD) are leading causes of vision loss in older adults. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely prescribed in the management of type 2 diabetes mellitus (T2DM), their effects on ocular disease risk remain largely unknown.

Materials And Methods: This retrospective cohort study evaluated the association between SGLT2i use and the risk of AMD and other age-related ocular conditions in adults aged ≥60 with T2DM, using a target trial emulation framework based on the TriNetX global health research network (2013-2025).

View Article and Find Full Text PDF

Peripheral vitreoretinal abnormality and its correlation with malignant glaucoma in nanophthalmos with secondary angle closure glaucoma.

Eye (Lond)

September 2025

Beijing Tongren Eye Center Research Ward, Beijing Tongren Hospital, Beijing Institute of Ophthalmology, Beijing Ophthalmology & Visual Sciences Key Laboratory, Capital Medical University, Beijing, China.

Background: To evaluate the peripheral vitreoretinal abnormality (PVA) and its correlation with the risk of malignant glaucoma (MG) in nanophthalmos with secondary angle closure glaucoma (NSACG).

Methods: This prospective case series included 47 NSACG eyes with axial length (AL) < 21 mm from 25 patients. PVA was defined as a hyperreflective echo at the peripheral vitreoretinal region under ultrasound biomicroscopy (UBM).

View Article and Find Full Text PDF

Prcis: Analysis of 1,175 Korean adults in the 2019 KNHANES study found that sensitization to house dust mites and birch pollen significantly increased glaucoma risk, while oak pollen sensitization showed a protective effect.

Background: The relationship between allergen sensitization and glaucoma remains poorly understood. This study investigated the association between specific allergen sensitization patterns and glaucoma risk using data from the 2019 Korea National Health and Nutrition Examination Survey.

View Article and Find Full Text PDF

Purpose: To investigate hand function and eye drop instillation success in adults with and without glaucoma.

Design: Cross-sectional pilot study.

Subjects: Adults aged ≥ 65 years with glaucoma who use eye drops daily and adults aged 65+ without glaucoma who do not regularly use eye drops.

View Article and Find Full Text PDF

BackgroundGlaucoma is recognized as the second-leading cause of complete blindness in developed countries and a significant contributor to irreversible vision loss worldwide. Understanding the potential genetic links between neurodegenerative diseases, such as Parkinson's disease, and glaucoma is crucial for developing preventive strategies.MethodsThis study utilized data from Genome-Wide Association Studies databases, focusing on European populations without gender restrictions.

View Article and Find Full Text PDF